Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 110
News
News | 03 November 2023

The Prostate Cancer Foundation and Bayer announce Bayer – PCF Darolutamide Challenge Awards

In 2022, darolutamide was FDA-approved in combination with docetaxel chemotherapy for adults with metastatic hormone-sensitive prostate cancer

News
News | 03 November 2023

Lyka Labs posts Q2 FY24 loss at Rs. 48.65 lakhs

Lyka Labs has reported total income of Rs. 28.23 crores during the period ended September 30, 2023

News
News | 03 November 2023

Morepen Laboratories posts Q2 FY24 consolidated PAT at Rs. 21.25 Cr

Morepen Laboratories has reported total income of Rs. 425 crores during the quarter ended September 30, 2023

News
News | 03 November 2023

Dabur India posts Q2 FY24 consolidated PAT at Rs. 515.05 Cr

The company has posted net profit of Rs.978.93 crores for the 6 months period ended September 30, 2023

News
News | 03 November 2023

Lincoln Pharmaceuticals posts Q2 FY24 consolidated PAT at Rs. 27.65 Cr

Lincoln Pharmaceuticals has reported total income of Rs. 164.68 crores during the period ended September 30, 2023

News
News | 03 November 2023

Dr Lal Path Labs posts Q2 FY24 consolidated PAT at Rs. 109.3 Cr

Dr. Lal Path Labs has reported total income of Rs. 619.4 crores during the period ended September 30, 2023

News
News | 02 November 2023

Jubilant Ingrevia posts Q2 FY24 consolidated PAT at Rs. 57.49 Cr

The company has posted net profit of Rs.115.08 crores for half year ended September 30, 202

News
News | 02 November 2023

Zydus acquires UK based LiqMeds Group

Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026

News
News | 02 November 2023

Sun Pharmaceutical Industries Q2 FY 24 consolidated PAT higher at Rs. 2375.51 Cr

Sun Pharmaceutical Industries has reported total income of Rs. 12486.02 crores during the period ended September 30, 2023

News
News | 01 November 2023

Mankind Pharma Q2 FY24 consolidated PAT higher at Rs. 501.02 Cr

Mankind Pharma has reported total income of Rs. 2768.07 crores during the period ended September 30, 2023

News
News | 01 November 2023

Thyrocare Technologies posts Q2 FY24 consolidated PAT at Rs. 20.34 Cr

Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023

News
News | 01 November 2023

Ajanta Pharma posts Q2 FY24 consolidated PAT at Rs. 195.30 Cr

Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023

News
News | 01 November 2023

Pfizer posts Q3 loss as Covid-19 revenues shrink

Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion

News
News | 31 October 2023

Sun Pharma to co-market Zydus’s CKD treatment drug ‘Desidustat’ in India

The drug will be marketed by Sun Pharma under the brand name RYTSTAT

News
News | 31 October 2023

Alkem ‘Healthy Lungs' initiative aims to clear the air

The initiative will focus on advocating for cleaner air

News
News | 31 October 2023

Lubrizol launches carbopol polymers for nutraceuticals with new EU good grade approval

The European Commission approved the use of Carbopol as an additive for liquid and solid food supplements in the EU

News
News | 30 October 2023

Tanaka develops first high entropy precious metals alloy powder

With the establishment of five different precious metals alloy powder production methods

News
News | 30 October 2023

Dr Reddy's Q2 FY24 PAT jumps 33% to Rs 1,480 Cr

Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter

News
News | 30 October 2023

Pfizer and BioNTech announce data for mRNA-based vaccine program for influenza and COVID-19

The companies plan to start a pivotal Phase 3 trial in the coming months

News
News | 26 October 2023

Venus Remedies earns REO Certification from CII for second consecutive year

The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)

Startup

Digitization